Patent details

Basic Information

Publication number:

EP1541197

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP040250359

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Use of pipamperone and an SNDRI, SNRI or SSRI for the treatment of mood or anxiety disorders

French Title of Invention:

Utilisation de pipamperone et d'un SNDRI, SNRI ou SSRI pour le traitement des troubles de l'humeur ou anxieux

German Title of Invention:

Verwendung von Pipamperon und einem SNDRI, SNRI oder SSRI zur Behandlung von Stimmungs- oder Angststörungen

SPC Number:

Dates

Filing date:

21/10/2004

Grant date:

18/03/2009

EP Publication Date:

18/03/2009

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/06/2005

EP B1 Publication Date:

18/03/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/10/2013

Expiration date:

21/10/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/10/2004

 

 

Name:

PharmaNeuroBoost N.V.

Address:

Alkerstraat 30A, 3570 Alken, Belgium (BE)

Agent

Name:

DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT

From:

08/05/2009

Address:

PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

Name:

Buntinx Erik

Address:

Belgium (BE)

Priority

1

Priority Number:

03447279

Priority Date:

02/12/2003

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

04447001

Priority Date:

05/01/2004

Priority Country:

European Patent Office (EPO) (EP)

3

Priority Number:

04447066

Priority Date:

18/03/2004

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

A61K 31/343;

Filing date	Document type	Number of pages